551 Pegasus Skin, a study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL2) with cemiplimab for the treatment of participants with advanced unresectable or metastatic skin cancers

Bibliographic Details
Main Authors: Paolo A Ascierto, Giovanni Abbadessa, Brigitte Demers, PARK John, Adyb Baakili, Rao Saleem, Alice Gosselin
Format: Article
Language:English
Published: BMJ Publishing Group 2021-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items